Autism Spectrum Disorder affects 1 in 54 children and their families.

What We're Doing

PrimeNeuro is building software to support autism diagnosis and clinical care in infants as early as 6 months old.

Every child with autism is unique. Any solution that attempts to predict or diagnose autism must consider the wide range of variability in how the disorder presents. PrimeNeuro is building a solution to help doctors, parents, and educators understand how a child’s unique, developing brain may be growing and if that might include autism. Our goal is to predict this development in children as young as 6 months old. This is more than a year before most children begin to show any symptoms of autism, and 1 to 4 years before a diagnosis is typically made.

Early diagnosis matters! The brain is still developing, and a child’s growth trajectory and quality of life can be dramatically changed and improved with early intervention. Effective, life-altering interventions are available at 6 to 36+ months of age but require an early diagnosis. It is PrimeNeuro’s passion and mission to deliver an early diagnosis through our innovative technology to families and those that support them.

Our Values

We believe in growing neurodiversity. The number of children diagnosed with autism is growing rapidly, and we appreciate the complexity of a growing brain. We see a need for solutions that can help families and doctors understand and embrace neurodiversity in an ever-increasing population of children on the spectrum.

We believe in supporting and engaging with the autism community, including regularly interacting with parents raising children with autism and providing opportunities for autistic adults to engage in building our company. 

We believe that having the right data makes all the difference, and that we can make a difference with the right data. The developing brain is complex, but we have ways of learning how it is growing. This can inform treatments and answer questions about a child’s symptoms or behavior. 

We believe that data leads to understanding, understanding leads to empathy, and empathy leads to connection. With autism, every experience is unique, and that can naturally make families living with autism feel alone. The more we can understand how the brain is growing, the more we can understand how to connect through those differences.

1 in 54 children in the US is diagnosed with autism spectrum disorder.

What is Autism?

1 in 54 children in the US is diagnosed with Autism Spectrum Disorder (ASD). There are well over 1,000,000 children under the age of 18 living with autism in the US, and that number is increasing at a rate greater than 10% annually. The likelihood of a child being on the spectrum is 10 times higher if they have a sibling diagnosed with the disorder.

Though autism presents differently in every child, a child with ASD may have differences that include:

  • Social and Communication Issues
  • Focus on Narrow Interests
  • Repetitive Behaviors
  • Reduced or Heightened Response to Sensory Stimuli

Additionally, many children with autism also have co-occurring conditions, such as attention deficit hyperactive disorder (ADHD).

The science behind PrimeNeuro's mission

There is compelling clinical research evidence that measuring certain features of the brain, such as brain volume, the shape of regions of the brain, and how regions of the brain communicate, can be used to predict if a 6-month-old infant may develop to have autism.¹

Machine Learning algorithms are incredibly effective at finding patterns that humans cannot. Machine learning can identify patterns in brain connections and brain shapes that can distinguish children with autism, or those who may develop autism, from children without the disorder.²

Doctor measuring circumference of infant's skull

As Featured In

Cutting-edge technology paves the way for new solutions.

We use a novel approach that applies advanced machine learning algorithms to compare an MRI image of a child’s brain with a library of other images across thousands of unique features. The information we extract can be used to inform early interventions and help families successfully prepare to raise their amazing and special child in ways that benefit optimal growth and development.

Meet the PrimeNeuro Team

Sam Tetlow, President & Co-Founder of PrimeNeuro

Sam Tetlow, MBA

President, Co-Founder

Brad Bower, CEO and Co-Founder of PrimeNeuro

Brad Bower, PhD

CEO, Co-Founder

Sandy Throckmorton, Data Scientist, SignalAnalysisSolutions

Sandy Throckmorton, PhD

Data Scientist

Dhruman Goradia, Research Scientist for PrimeNeuro

Dhruman Goradia, PhD

Research Scientist

Kenneth Barrett, Data Entry Specialist for PrimeNeuro

Kenneth Barrett

Data Entry Specialist

Systems Architecture Support Provided By The Fifedom

Contact Us

PrimeNeuro

2 Davis Dr.
Durham, NC 27703

         

Citations

¹ Emerson, R. W., Adams, C., Nishino, T., Hazlett, H. C., Wolff, J. J., Zwaigenbaum, L., … Piven, J. (2017). Functional neuroimaging of high-risk 6-month-old infants predicts a diagnosis of autism at 24 months of age. Science Translational Medicine, 9(393), eaag2882.
² Hazlett, H. C., Gu, H., Munsell, B. C., Kim, S. H., Styner, M., Wolff, J. J., … Piven, J. (2017). Early brain development in infants at high risk for autism spectrum disorder. Nature, 542(7641), 348–351.